JONAS JEFFREY M — SEC Form 4 filings
SEC reporting owner CIK 1042021. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-18 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Generation Bio Co. (GBIO) | Director | 3 | — | — | 9 |
| Karuna Therapeutics, Inc. (KRTX) | Director | 1 | — | — | 7 |
| COMPASS Pathways plc (CMPS) | Director | 2 | — | — | 2 |
| Sage Therapeutics, Inc. (SAGE) | Director | 1 | — | — | 1 |
Form 4 filings — JONAS JEFFREY M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 21,110 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Generation Bio Co. (GBIO) | Disposition to issuer (D): 3,000 (derivative) · Disposition to issuer (D): 4,246 (derivative) · Disposition to issuer (D): 5,200 (derivative) · Disposition to issuer (D): 1,500 (derivative) · Disposition to issuer (D): 1,920 (derivative) · Disposition to issuer (D): 2,500 (derivative) · +1 more | EDGAR |
| 2025-10-31 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Generation Bio Co. (GBIO) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Generation Bio Co. (GBIO) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 19,893 (derivative) @ $322.73 · Disposition to issuer (D): 16,250 (derivative) @ $314 · Disposition to issuer (D): 12,500 (derivative) @ $232.41 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1042021 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →